Allergy/Asthma Specialist, Pediatrician, Business Owner, Retired Colonel (United States Air Force), Father of eight, grandfather to 23 and husband to one
New research from the OUtMATCH trial offers encouraging insights for people living with multiple food allergies. Researchers found that about 1 in 3 patients treated with omalizumab (Xolair) were able to tolerate full servings (4,044 mg or more) of three different foods they were allergic to by the end of treatment period. The study also found that participants treated with omalizumab experienced fewer cases of anaphylaxis. While omalizumab is not a cure for food allergy, these findings add to growing evidence that it may help increase protection against accidental exposures for some people living with multiple food allergies. FARE is committed to advancing food allergy research and keeping our community informed about the latest scientific developments. As always, treatment decisions should be made in partnership with an allergist to determine the best approach for each individual's needs.
Read FARE's OUtMATCH Summary here: https://t.co/bNEGT9lDY8
Marshall Stierer, just 13, faced leukemia twice and passed away unexpectedly, leaving his family overwhelmed with emotional and financial stress. This fundraiser helps cover medical bills, lost wages, and related costs during this difficult time. I’ve already donated because supporting families like theirs matters to me. The fundraiser is close to reaching its goal—if you’re able, please consider donating or sharing to help them find some relief. https://t.co/NgseAoHDyg
This review article comprehensively describes approved and novel investigational biologic and other therapeutic strategies that target IgE-mediated and non-IgE-mediated pathways for the treatment and ideally remission of food allergy: https://t.co/GzK8oCwgrv
As if protecting you against influenza triggered hospitalization or death wasn’t enough, now it appears influenza vaccines can lower your dementia risk! Just do it! https://t.co/a4tTy1tQdF
Dentists still write millions of prescriptions a year for an antibiotic with life-threatening risks https://t.co/VaPuluIVT0
Article notes clindamycin is prescribed to dental patients thought penicillin allergic. Note: >90% of patients labeled penicillin are not. See an allergist
https://t.co/VtE0uOCFIh
The reality of private practice financial challenges today…I have physician friends who are choosing to sell their practices to venture capital/private equity backed large groups as they watch their headaches increase and personal earnings decrease.
Rising trends in infant ER encounters for food-induced allergic reacti... https://t.co/88BXJmHd9e
It is important to work with an allergist to reduce the risk of severe food reactions in children. They have the experience to guide families struggling with this problem.